---------- Levocarnitine is a carrier molecule in the transport of long-chain fatty acids across the inner mitochondrial membrane
Notably, the EMPEROR-Preserved trial demonstrated that empagliflozin significantly reduced cardiovascular mortality and hospitalization in HFpEF patients without increasing adverse events
In particular, they produce ATP, which leads to falsely high results when AK inhibitors in the CK reaction are exhausted
Patients whose BMI falls between 25 and 29.9 may still qualify if they have documented metabolic syndrome, sleep apnea, cardiovascular disease, or other obesity-related conditions
Many people are good candidates for mini tummy tuck surgery
If we treat those patients with proactive therapies before they have a heart attack, we can often prevent it. Another valuable diagnostic tool is calcium CT scoring